Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Defence Therapeutics Inc (DTCFF)

Defence Therapeutics Inc (DTCFF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6180 -0.0267 (-4.14%) 04/25/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.6180 unch (unch) 10:00 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.6180
Day High
0.6180
Open 0.6180
Previous Close 0.6447 0.6447
Volume 500 500
Avg Vol 20,445 20,445
Stochastic %K 66.54% 66.54%
Weighted Alpha -28.82 -28.82
5-Day Change -0.1710 (-21.67%) -0.1710 (-21.67%)
52-Week Range 0.2732 - 1.1575 0.2732 - 1.1575
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6180 unch
on 04/25/25
Period Open: 0.9964
0.6447 -4.14%
on 04/10/25
-0.3784 (-37.98%)
since 03/11/25
3-Month
0.6180 unch
on 04/25/25
Period Open: 0.6079
1.1575 -46.61%
on 02/20/25
+0.0101 (+1.66%)
since 01/24/25
52-Week
0.2732 +126.21%
on 12/17/24
Period Open: 0.8765
1.1575 -46.61%
on 02/20/25
-0.2585 (-29.49%)
since 04/25/24

Most Recent Stories

More News
Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies

Montreal, Quebec--(Newsfile Corp. - April 8, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing advanced...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)
Defence Announces US Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Defence's Management Team as Chief Operating Officer

Montreal, Quebec--(Newsfile Corp. - March 26, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)
Defence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million

Montreal, Quebec--(Newsfile Corp. - January 31, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)
Defence to Connect with Industry Leaders and Potential Partners During the JP Morgan Healthcare Conference in San Francisco. Plans to Expand the Next Generation of Radio-Immuno Conjugates in 2025

Montreal, Quebec--(Newsfile Corp. - January 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company") a Canadian biopharmaceutical company developing radiopharmaceuticals...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)
Defence Fortifies Patent Portfolio

Vancouver, British Columbia--(Newsfile Corp. - January 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)
Defence Arranges Financing

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)
Defence Announces Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Its Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - December 20, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)
Defence Provides Update on Delivery of AGSM Proxy Materials

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)
Defence's Proprietary Accum Technology Ready to License to Companies Developing Antibody Drug Conjugates (ADC)

Vancouver, British Columbia--(Newsfile Corp. - November 29, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)
Defence Announces Dr. Maxime Parisotto as CSO, Director of Science and Business Development

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6180 (-4.14%)
DTC.CN : 0.8200 (+2.50%)

Key Turning Points

3rd Resistance Point 0.6180
2nd Resistance Point 0.6180
1st Resistance Point 0.6180
Last Price 0.6180
1st Support Level 0.6180
2nd Support Level 0.6180
3rd Support Level 0.6180

See More

52-Week High 1.1575
Fibonacci 61.8% 0.8197
Fibonacci 50% 0.7154
Last Price 0.6180
Fibonacci 38.2% 0.6110
52-Week Low 0.2732

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar